Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04732065
Title ONC206 for Treatment of Newly Diagnosed or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sabine Mueller, MD, PhD

brain ependymoma

diffuse midline glioma, H3 K27M-mutant

brain cancer

spinal cord glioma

high grade glioma



Age Groups: child | adult
Covered Countries USA

No variant requirements are available.